Ruthenium(II)-arene complex induces apoptosis in lung cancer cells
Author Information
Author(s): Zhang Gen, Wu Chunhui, Ye Hongde, Yan Hong, Wang Xuemei
Primary Institution: State Key Lab of Bioelectronics, Southeast University
Hypothesis
The ruthenium(II)-arene complex can induce apoptosis in human lung cancer cells.
Conclusion
The ruthenium(II)-arene complex significantly induces apoptosis in human lung cancer HCC827 cells and shows potential as a chemotherapeutic agent.
Supporting Evidence
- The ruthenium(II)-arene complex showed significant cytotoxicity to HCC827 cells.
- IC50 values for the complex were calculated to be 19.6 ± 5.3 μM.
- Apoptosis was confirmed through various assays including Annexin-V-FITC and DNA fragmentation analysis.
- Treatment resulted in a dose-dependent increase in apoptotic cells.
Takeaway
A new compound made from ruthenium can help kill lung cancer cells by making them die in a special way called apoptosis.
Methodology
The study involved treating HCC827 lung cancer cells with various concentrations of the ruthenium(II)-arene complex and measuring cell viability and apoptosis through MTT assays and flow cytometry.
Participant Demographics
Human lung cancer HCC827 cell line.
Statistical Information
P-Value
19.6 ± 5.3 μM
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website